Innovative Medical: all 51 studies

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of OsmolarityStatus unknownNCT01386073Phase 4
• Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract SurgeryCompletedNCT01383057Phase 4
• Laser Cataract Surgery With the Femtosecond Laser TechnologyCompletedNCT01382823Phase 4
• Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and SymptomsStatus unknownNCT01382810Phase 4
• Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract SurgeryStatus unknownNCT01382641Phase 4
• Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract IncisionsCompletedNCT01298973Phase 4
• Evaluation of Visual Outcomes of Monovision Patients Bilaterally Implanted With Nanoflex Intraocular LensesStatus unknownNCT01279122Phase 4
• Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled TrialCompletedNCT01279031Phase 4
• AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOLStatus unknownNCT01278420Phase 4
• Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following PhacoemulsificationStatus unknownNCT01193504Phase 4
• Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast StudyStatus unknownNCT01191515
• Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle IndependenceCompletedNCT01191502
• Prospective Evaluation of Visual Outcomes With Tecnis One-Piece Multifocal Intraocular Lenses Compared With Patients Previously Implanted With Crystalens Aspheric Optic (AO)CompletedNCT01191229Phase 4
• An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic PatientsCompletedNCT01173198Phase 4
• Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular LensesCompletedNCT01061918Phase 4
• Evaluation of Outcomes Using the AMO Advanced Customvue™ iLasik ProcedureCompletedNCT01061294Phase 4
• Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular LensesCompletedNCT01061281Phase 4
• A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular LensCompletedNCT01061268Phase 4
• Prospective Health Assessment of Cataract Patients' Ocular SurfaceCompletedNCT01016405
• An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular LensesCompletedNCT01004549
• Topical Cyclosporine and Disease ProgressionCompletedNCT00567983Phase 4
• Objective Measurements of Prolonged Effects of Restasis on Dry Eye DiseaseCompletedNCT00567177Phase 4
• Comfort and Cleaning Evaluation of Multipurpose Solutions in Contact Lens PatientsCompletedNCT00519948Phase 4
• Comfort Evaluation of a New MPS vs. Replenish in Contact Lens PatientsCompletedNCT00518700Phase 4
• Cross-Over Evaluation of Two Lubricating Eye DropsCompletedNCT00493662Phase 4
• An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin AgingTerminatedNCT00492479Phase 4
• Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal StainingCompletedNCT00483795Phase 4
• Oasys vs. Extreme H20 Xtra 59CompletedNCT00477763Phase 4
• Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug EffectsCompletedNCT00469690Phase 4
• Safety and Efficacy of Optive in Contact Lens Wearers With Dry EyesCompletedNCT00469573Phase 4
• Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear ThicknessCompletedNCT00469521Phase 4
• Refractive Surgery and Optive Compatibility StudyCompletedNCT00469157Phase 4
• Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of ScarsCompletedNCT00450775Phase 4
• Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL ImplantationCompletedNCT00433225Phase 4
• Therapeutic Variables in Cataract SurgeryCompletedNCT00407017Phase 4
• Comparison of Frequency of Use of Optive and SystaneCompletedNCT00406510Phase 4
• Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye SymptomsCompletedNCT00405457Phase 4
• A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry EyeCompletedNCT00399230Phase 4
• Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye SymptomsCompletedNCT00399061Phase 4
• Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to PterygiaCompletedNCT00383396Phase 4
• Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%CompletedNCT00377546Phase 4
• Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL ImplantationCompletedNCT00349583Phase 4
• Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive KeratectomyCompletedNCT00349440Phase 4
• Acular LS vs. Nevanac in Post op Inflammation Following Cataract SurgeryCompletedNCT00348582Phase 4
• Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to LatanoprostCompletedNCT00348400Phase 4
• Ketorolac vs. Steroid in the Prevention of CMECompletedNCT00348244Phase 4
• A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular HypertensionCompletedNCT00348062Phase 4
• Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular HypertensionCompletedNCT00348023Phase 4
• Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to LatanoprostCompletedNCT00347841Phase 4
• Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%CompletedNCT00347802Phase 4
• Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract PatientsCompletedNCT00347503Phase 4

← Innovative Medical overview and focus areas